Status:
UNKNOWN
Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-Vivo
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The role played by ß2AR polymorphisms in determining the bronchial response to ß2AR agonist drugs, has been confirmed by several studies. The purpose of the present study is to examine possible causa...
Eligibility Criteria
Inclusion
- Macroscopically normal pulmonary tissue
Exclusion
- The presence of pathological finding in the pulmonary tissue
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00162422
Start Date
August 1 2003
Last Update
October 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel